Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Clinical Study on Immunogenicity Persistence of Adsorbed 5-component Acellular Pertussis, Diphtheria and Tetanus Combined Vaccine

NCT07744347 is registered in ClinicalTrials.gov with CanSino Biologics Inc. as lead sponsor.

NCT NCT07744347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07744347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Clinical Study on Immunogenicity Persistence of Adsorbed 5-component Acellular Pertussis, Diphtheria and Tetanus Combined Vaccine
Lead sponsor
CanSino Biologics Inc.
Phase
Observational
Overall status
Not yet recruiting
Start date
October 15, 2026
Completion date
October 15, 2033
Enrollment
160 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diphtheria, pertussis, tetanus